Muscle wasting in animal models of severe illness

International Journal of Experimental Pathology

Volumn 93, Issue 3, 2012, Pages 157-171

  Holecek, Milan ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Cachexia; Cancer; Chronic heart failure; Intensive care unit patients; Liver cirrhosis; Obstructive pulmonary disease; Renal failure; Sepsis

Indexed keywords

ENDOTOXIN; NEUROMUSCULAR BLOCKING AGENT; TOLL LIKE RECEPTOR 4;

ADENOCARCINOMA; APPENDICITIS; BILE DUCT LIGATION; BODY WEIGHT; CACHEXIA; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; COLORECTAL CARCINOMA; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DIVERTICULITIS; EMPHYSEMA; HEART FAILURE; HEART INFARCTION; INTENSIVE CARE UNIT; INTESTINE FLORA; LEWIS CARCINOMA; LIVER CIRRHOSIS; MELANOMA; MORRIS HEPATOMA; MUSCLE ATROPHY; NEOPLASM; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; REVIEW; SEPSIS; SKELETAL MUSCLE; WALKER CARCINOMA; WEIGHT REDUCTION; YOSHIDA SARCOMA;

EID: 84860991658     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2012.00812.x     Document Type: Review

References (144)

1. Acharyya S., Ladner K.J., Nelsen L.L. et al. (2004) Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J. Clin. Invest. 114, 370-378.
2. Akashi Y.J., Palus S., Datta R. et al. (2009) No effects of human ghrelin on cardiac function despite profound effects on body composition in a rat model of heart failure. Int. J. Cardiol. 137, 267-275.
3. Ash S.A. & Griffin G.E. (1989) Effect of parenteral nutrition on protein turnover in endotoxaemic rats. Clin. Sci. 76, 659-666.
4. Bailey J.L., Wang X., England B.K., Price S.R., Ding X., Mitch W.E. (1996) The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. J. Clin. Invest. 97, 1447-1453.
5. Ballmer P.E., McNurlan M.A., Hulter H.N., Anderson S.E., Garlick P.J., Krapf R. (1995) Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans. J. Clin. Invest. 95, 39-45.
6. Baltgalvis K.A., Berger F.G., Peña M.M., Mark Davis J., White J.P., Carson J.A. (2010) Activity level, apoptosis, and development of cachexia in Apc(Min/+) mice. J. Appl. Physiol. 109, 1155-1161.
7. Baracos V.E., DeVivo C., Hoyle D.H., Goldberg A.L. (1995) Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma. Am. J. Physiol. 268, E996-E1006.
8. Beehler B.C., Sleph P.G., Benmassaoud L., Grover G.J. (2006) Reduction of skeletal muscle atrophy by a proteasome inhibitor in a rat model of denervation. Exp. Biol. Med. (Maywood) 231, 335-341.
9. Blonde-Cynober F., Plassart F., Rey C. et al. (1994) Assessment of the carbon tetrachloride-induced cirrhosis model for studies of nitrogen metabolism in chronic liver disease. Ann. Nutr. Metab. 38, 238-248.
10. Bolton C.F. (2000) Evidence of neuromuscular dysfunction in the early stages of the systemic inflammatory response syndrome. Intensive Care Med. 26, 1179-1180.
11. Boudet J., Man N.K., Pils P., Sausse A., Funck-Brentano J.L. (1978) Experimental chronic renal failure in the rat by electrocoagulation of the renal cortex. Kidney Int. 14, 82-86.
12. Breuille D., Voisin L., Contrepois M., Arnal M., Rose F., Obled C. (1999) A sustained rat model for studying the long-lasting catabolic state of sepsis. Infect. Immun. 67, 1079-1085.
13. Buras J.A., Holzmann B., Sitkovsky M. (2005) Animal models of sepsis: setting the stage. Nat. Rev. Drug. Discov. 4, 854-865.
14. Busquets S., Figueras M.T., Fuster G. et al. (2004) Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting. Cancer Res. 64, 6725-6731.
15. Cahlin C., Gelin J., Delbro D., Lönnroth C., Doi C., Lundholm K. (2000) Effect of cyclooxygenase and nitric oxide synthase inhibitors on tumor growth in mouse tumor models with and without cancer cachexia related to prostanoids. Cancer Res. 60, 1742-1749.
16. Cannon T., Couch M., Yin X., Guttridge D., Lai V., Shores C. (2007) Comparison of animal models for head and neck cancer cachexia. Laryngoscope 117, 2152-2158.
17. Caso G. & Garlick P.J. (2005) Control of muscle protein kinetics by acid-base balance. Curr. Opin. Clin. Nutr. Metab. Care. 8, 73-76.
18. Chai J., Wu Y., Sheng Z.Z. (2003) Role of ubiquitin-proteasome pathway in skeletal muscle wasting in rats with endotoxemia. Crit. Care Med. 31, 1802-1807.
19. Combaret L., Adegoke O.A., Bedard N., Baracos V., Attaix D., Wing S.S. (2005) SP19 is a ubiquitin-specific protease regulated in rat skeletal muscle during catabolic states. Am. J. Physiol. 288, E693-E700.
20. Costelli P., Muscaritoli M., Bossola M. et al. (2006) IGF-1 is downregulated in experimental cancer cachexia. Am. J. Physiol. 291, R674-R683.
21. Cross A.S., Opal S.M., Sadoff J.C., Gemski P. (1993) Choice of bacteria in animal models of sepsis. Infect. Immun. 61, 2741-2747.
22. De Jonghe B., Lacherade J.C., Sharshar T., Outin H. (2009) Intensive care unit-acquired weakness: risk factors and prevention. Crit. Care Med. 37, S309-S315.
23. De Paepe B., Brusselle G.G., Maes T. et al. (2008) TNF alpha receptor genotype influences smoking-induced muscle-fibre-type shift and atrophy in mice. Acta Neuropathol. 115, 675-681.
24. Decramer M., Lacquet L.M., Fagard R., Rogiers P. (1994) Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am. J. Respir. Crit. Care Med. 150, 11-16.
25. Fareed M.U., Evenson A.R., Wei W. et al. (2006) Treatment of rats with calpain inhibitors prevents sepsis-induced muscle proteolysis independent of atrogin-1/MAFbx and MuRF1 expression. Am. J. Physiol. 290, R1589-R1597.
26. Fields A.L., Wolman S.L., Cheema-Dhadli S., Morris H.P., Halperin M.L. (1981) Regulation of energy metabolism in Morris hepatoma 7777 and 7800. Cancer Res. 41, 2762-2766.
27. Fink M.P. & Heard S.O. (1990) Laboratory models of sepsis and septic shock. J. Surg. Res. 49, 186-196.
28. Fischer D., Gang G., Pritts T., Hasselgren P.O. (2000) Sepsis-induced muscle proteolysis is prevented by a proteasome inhibitor in vivo. Biochem. Biophys. Res. Commun. 270, 215-221.
29. Fish R.E. & Spitzer J.A. (1984) Continuous infusion of endotoxin from an osmotic pump in the conscious, unrestrained rat: a unique model of chronic endotoxemia. Circ. Shock 12, 135-149.
30. Friedrich O., Hund E., Weber C., Hacke W., Fink R.H. (2004) Critical illness myopathy serum fractions affect membrane excitability and intracellular calcium release in mammalian skeletal muscle. J. Neurol. 251, 53-65.
31. Gayan-Ramirez G., van de Casteele M., Rollier H. et al. (1998) Biliary cirrhosis induces type IIx/b fibre atrophy in rat diaphragm and skeletal muscle, and decreases IGF-I mRNA in the liver but not in muscle. J. Hepatol. 29, 241-249.
32. Gilson H., Schakman O., Combaret L. et al. (2007) Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy. Endocrinology 148, 452-460.
33. Gosker H.R., Langen R.C., Bracke K.R. et al. (2009) Extrapulmonary manifestations of chronic obstructive pulmonary disease in a mouse model of chronic cigarette smoke exposure. Am. J. Respir. Cell Mol. Biol. 40, 710-716.
34. Hanada T., Toshinai K., Date Y. et al. (2004) Upregulation of ghrelin expression in cachectic nude mice bearing human melanoma cells. Metabolism 53, 84-88.
35. Hasselgren P.O. & Fischer J.E. (1998) Sepsis: stimulation of energy-dependent protein breakdown resulting in protein loss in skeletal muscle. World J. Surg. 22, 203-208.
36. Héliès-Toussaint C., Moinard C., Rasmusen C., Tabbi-Anneni I., Cynober L., Grynberg A. (2005) Aortic banding in rat as a model to investigate malnutrition associated with heart failure. Am. J. Physiol. 288, R1325-R1331.
37. Hingorani S.R., Wang L., Multani A.S. et al. (2005) Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7, 469-483.
38. Hobler S.C., Tiao G., Fischer J.E., Monaco J., Hasselgren P.O. (1998) Sepsis-induced increase in muscle proteolysis is blocked by specific proteasome inhibitors. Am. J. Physiol. 274, R30-R37.
39. Holecek M. (1996) Leucine metabolism in fasted and TNF treated rats. Clin. Nutr. 15, 91-93.
40. Holecek M. (2002) Relation between glutamine, branched-chain amino acids, and protein metabolism. Nutrition 18, 130-133.
41. Holecek M., Skopec F., Sprongl L. (1995a) Protein metabolism in cirrhotic rats: effect of dietary restriction. Ann. Nutr. Metab. 39, 346-354.
42. Holecek M., Skopec F., Sprongl L., Pecka M. (1995b) Protein metabolism in specific tissues of endotoxin-treated rats: effect of nutritional status. Physiol. Res. 44, 399-406.
43. Holecek M., Mraz J., Tilser I. (1996a) Plasma amino acids in four models of experimental liver injury in rats. Amino Acids 10, 229-241.
44. Holecek M., Tilser I., Skopec F., Sprongl L. (1996b) Leucine metabolism in rats with cirrhosis. J. Hepatol. 24, 209-216.
45. Holecek M., Sprongl L., Tichy M., Pecka M. (1998) Leucine metabolism in rat liver after a bolus injection of endotoxin. Metab. Clin. Exp. 47, 681-685.
46. Holecek M., Sprongl L., Tichy M. (2000a) Effect of hyperammonemia on leucine and protein metabolism in rats. Metab. Clin. Exp. 49, 1330-1334.
47. Holecek M., Skopec F., Skalska H., Sprongl L. (2000b) Effect of alanyl-glutamine on leucine and protein metabolism in endotoxemic rats. JPEN J. Parenter. Enteral. Nutr. 24, 215-222.
48. Holecek M., Sprongl L., Tilser I., Tichy M. (2000c) Leucine and protein metabolism after bilateral nephrectomy in rats: the role of hepatic tissue. Res. Exp. Med. 200, 53-65.
49. Holecek M., Sprongl L., Tilser I., Tichy M. (2001) Leucine and protein metabolism in rats with chronic renal insufficiency. Exp. Toxicol. Pathol. 53, 71-76.
50. Holecek M., Safranek R., Rysava R., Kadlcikova J., Sprongl L. (2003) Acute effects of acidosis on protein and amino acid metabolism in perfused rat liver. Int. J. Exp. Pathol. 84, 185-190.
51. Holecek M., Muthny T., Kovarik M., Sispera L. (2006) Simultaneous infusion of glutamine and branched-chain amino acids (BCAA) to septic rats does not have more favorable effect on protein synthesis in muscle, liver, and small intestine than separate infusions. JPEN J. Parenter. Enteral. Nutr. 30, 467-473.
52. Holecek M., Muthny T., Kovarik M., Sispera L. (2009) Effect of beta-hydroxy-beta-methylbutyrate (HMB) on protein metabolism in whole body and in selected tissues. Food Chem. Toxicol. 47, 255-259.
53. Holecek M., Kandar R., Sispera L., Kovarik M. (2011) Acute hyperammonemia activates branched-chain amino acid catabolism and decreases their extracellular concentrations: different sensitivity of red and white muscle. Amino Acids 40, 575-584.
54. Hummel R.P., James J.H., Warner B.W., Hasselgren P.O., Fischer J.E. (1988) Evidence that cathepsin B contributes to skeletal muscle protein breakdown during sepsis. Arch. Surg. 123, 221-224.
55. Ijichi H. (2011) Genetically-engineered mouse models for pancreatic cancer: advances and current limitations. World J. Clin. Oncol. 2, 195-202.
56. Jepson M.M., Pell J.M., Bates P.C., Millward D.J. (1986) The effects of endotoxaemia on protein metabolism in skeletal muscle and liver of fed and fasted rats. Biochem. J. 235, 329-336.
57. Jin B. & Li Y.P. (2007) Curcumin prevents lipopolysaccharide-induced atrogin-1/MAFbx upregulation and muscle mass loss. J. Cell. Biochem. 100, 960-969.
58. 3VS on protein metabolism in septic rats. Int. J. Exp. Pathol. 85, 365-371.
59. Kayali A.G., Young V.R., Goodman M.N. (1987) Sensitivity of myofibrillar proteins to glucocorticoid-induced muscle proteolysis. Am. J. Physiol. 252, E621-E626.
60. Khal J. & Tisdale M.J. (2008) Downregulation of muscle protein degradation in sepsis by eicosapentaenoic acid (EPA). Biochem. Biophys. Res. Commun. 375, 238-240.
61. Konno S. (2005) Hydroxyl radical formation in skeletal muscle of rats with glucocorticoid-induced myopathy. Neurochem. Res. 30, 669-675.
62. Kopple J.D. (1997) McCollum Award Lecture, 1996: protein-energy malnutrition in maintenance dialysis patients. Am. J. Clin. Nutr. 65, 1544-1557.
63. Kouidi E., Albani M., Natsis K. et al. (1998) The effects of exercise training on muscle atrophy in haemodialysis patients. Nephrol. Dial. Transplant. 13, 685-699.
64. Kountouras J., Billing B.H., Scheuer P.J. (1984) Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br. J. Exp. Pathol. 65, 305-311.
65. Kovarik M., Muthny T., Sispera L., Holecek M. (2010) Effects of β-hydroxy-β-methylbutyrate treatment in different types of skeletal muscle of intact and septic rats. J. Physiol. Biochem. 66, 311-319.
66. Labeit S., Kohl C.H., Witt C.C., Labeit D., Jung J., Granzier H. (2010) Modulation of muscle atrophy, fatigue and MLC phosphorylation by MuRF1 as indicated by hindlimb suspension studies on MuRF1-KO mice. J. Biomed. Biotechnol. 2010, 1-9.
67. Lang C.H., Bagby G.J., Bornside G.H., Vial L.J., Spitzer J.J. (1983) Sustained hypermetabolic sepsis in rats: characterization of the model. J. Surg. Res. 35, 201-210.
68. Lang C.H., Lynch C.J., Vary T.C. (2010) BCATm deficiency ameliorates endotoxin-induced decrease in muscle protein synthesis and improves survival in septic mice. Am. J. Physiol. 299, R935-R944.
69. Larson L. (2007) Experimental animal models of muscle wasting in intensive care unit patients. Crit. Care Med. 35, S484-S487.
70. Le Bricon T., Cynober L., Field C.J., Baracos V.E. (1995) Supplemental nutrition with ornithine alpha-ketoglutarate in rats with cancer-associated cachexia: surgical treatment of the tumor improves efficacy of nutritional support. J. Nutr. 125, 2999-3010.
71. Lin S.Y., Chen W.Y., Lee F.Y., Huang C.J., Sheu W.H. (2005) Activation of ubiquitin-proteasome pathway is involved in skeletal muscle wasting in a rat model with biliary cirrhosis: potential role of TNF-alpha. Am. J. Physiol. 288, E493-E501.
72. Loughna P. T. & Morgan M. J. (1999) Passive stretch modulates denervation induced alterations in skeletal muscle myosin heavy chain mRNA levels. Pflugers Arch. 439, 52-55.
73. Lundholm K., Edström S., Ekman L., Karlberg I., Bylund A.C., Scherstén T. (1978) A comparative study of the influence of malignant tumor on host metabolism in mice and man: evaluation of an experimental model. Cancer 42, 453-461.
74. Macallan D.C., Cook E.B., Preedy V.R., Griffin G.E. (1996) The effect of endotoxin on skeletal muscle protein gene expression in the rat. Int. J. Biochem. Cell Biol. 28, 511-520.
75. Madaro L., Smeriglio P., Molinaro M., Bouché M. (2008) Unilateral immobilization: a simple model of limb atrophy in mice. Basic Appl. Myol. 18, 149-153.
76. Man W.D., Kemp P., Moxham J., Polkey M.I. (2009) Skeletal muscle dysfunction in COPD: clinical and laboratory observations. Clin. Sci. (Lond) 117, 251-264.
77. Martorana P.A., Cavarra E., Lucattelli M., Lungarella G. (2006) Models for COPD involving cigarette smoke. Drug Discov. Today Dis. Models 3, 225-230.
78. Mattson J.P., Delp M.D., Poole D.C. (2004) Differential effects of emphysema on skeletal muscle fibre atrophy in hamsters. Eur. Respir. J. 23, 703-707.
79. Mattson J.P., Poole D.C., Hahn S.A., Musch T.I., Hinkle R.T., Isfort R.J. (2008) Maximal force is unaffected by emphysema-induced atrophy in extensor digitorium longus. Respir. Physiol. Neurobiol. 161, 119-124.
80. May R.C., Kelly R.A., Mitch W.E. (1986) Metabolic acidosis stimulates protein degradation in rat muscle by a glucocorticoid-dependent mechanism. J. Clin. Invest. 77, 614-621.
81. May R.C., Kelly R.A., Mitch W.E. (1987) Mechanisms for defects in muscle protein metabolism in rats with chronic uremia. Influence of metabolic acidosis. J. Clin. Invest. 79, 1099-1103.
82. May R.C., Bailey J.L., Mitch W.E., Masud T., England B.K. (1996) Glucocorticoids and acidosis stimulate protein and amino acid catabolism in vivo. Kidney Int. 49, 679-683.
83. McCart A.E., Vickaryous N.K., Silver A. (2008) Apc mice: models, modifiers and mutants. Pathol. Res. Pract. 204, 479-490.
84. Merli M., Riggio O., Romiti A. et al. (1990) Basal energy production rate and substrate use in stable cirrhotic patients. Hepatology 12, 106-112.
85. Mitch W.E., Medina R., Grieber S. et al. (1994) Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes. J. Clin. Invest. 93, 2127-2133.
86. Montano-Loza A.J., Meza-Junco J., Prado C.M. et al. (2012) Muscle wasting is associated with mortality in patients with cirrhosis. Clin. Gastroenterol. Hepatol. 10, 166-173.
87. Mori M., Yamaguchi K., Honda S. et al. (1991) Cancer cachexia syndrome developed in nude mice bearing melanoma cells producing leukemia-inhibitory factor. Cancer Res. 51, 6656-6659.
88. Morley J.E., Thomas D.R., Wilson M.M. (2006) Cachexia: pathophysiology and clinical relevance. Am. J. Clin. Nutr. 83, 735-743.
89. Mozaffar T., Haddad F., Zeng M., Zhang L.Y., Adams G.R., Baldwin K.M. (2007) Molecular and cellular defects of skeletal muscle in an animal model of acute quadriplegic myopathy. Muscle Nerve 35, 55-65.
90. Muscaritoli M., Costelli P., Bossola M. et al. (2003) Effects of simvastatin administration in an experimental model of cancer cachexia. Nutrition 19, 936-939.
91. Muthny T., Kovarik M., Sispera L., Tilser I., Holecek M. (2008) Protein metabolism in slow- and fast-twich muscle during turpentine-induce inflammation. Int. J. Exp. Pathol. 89, 64-71.
92. Nagaya N., Uematsu M., Kojima M. et al. (2001) Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 104, 1430-1435.
93. Ng E.H. & Lowry S.F. (1991) Nutritional support and cancer cachexia. Hematol. Oncol. Clin. North Am. 5, 161-194.
94. Norman H., Nordquist J., Andersson P. et al. (2006a) Impact of post-synaptic block of neuromuscular transmission, muscle unloading and mechanical ventilation on skeletal muscle protein and mRNA expression. Pflugers Arch. 453, 53-66.
95. Norman H., Kandala K., Kolluri R. et al. (2006b) A porcine model of acute quadriplegic myopathy: a feasibility study. Acta Anaesthesil. Scand. 50, 1058-1067.
96. Nystrom G., Pruznak A., Huber D., Frost R.A., Lang C.H. (2009) Local insulin-like growth factor I prevents sepsis-induced muscle atrophy. Metabolism 58, 787-797.
97. Ochala J & Larsson L. (2008) Effects of a preferential myosin loss on Ca2+ activation of force generation in single human skeletal muscle fibres. Exp. Physiol. 93, 486-495.
98. Ohira Y., Yoshinaga T., Nomura T. et al. (2002) Gravitational unloading effects on muscle fiber size, phenotype any myonuclear number. Adv. Space Res. 30, 777-781.
99. O'Keefe S., Abraham R., Davis M., Williams R. (1980) Protein turnover in acute and chronic liver disease. Acta Chir. Scand. 507, 91-100.
100. Olive K.P., Jacobetz M.A., Davidson C.J. et al. (2009) Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324, 1457-1461.
101. Palus S., Akashi Y., von Haehling S., Anker S.D., Springer J. (2009) The influence of age and sex on disease development in a novel animal model of cardiac cachexia. Int. J. Cardiol. 133, 388-393.
102. Peng S., Plank L.D., McCall J.L., Gillanders L.K., McIlroy K., Gane E.J. (2007) Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: a comprehensive study. Am. J. Clin. Nutr. 85, 1257-1266.
103. Pizato N., Bonatto S., Piconcelli M. et al. (2006) Fish oil alters T-lymphocyte proliferation and macrophage responses in Walker 256 tumor-bearing rats. Nutrition 22, 425-432.
104. Poehlmann E.T., Scheffers J., Gottlieb S.S., Fisher M.L., Vaitekevicius P. (1994) Increased resting metabolic rate in patients with congestive heart failure. Ann. Intern. Med. 121, 860-862.
105. Rabuel C., Renaud E., Brealey D. et al. (2004) Human septic myopathy: induction of cyclooxygenase, heme oxygenase and activation of the ubiquitin proteolytic pathway. Anesthesiology 101, 583-590.
106. Ruud J., Blomqvist A. (2007) Identification of rat brainstem neuronal structures activated during cancer-induced anorexia. J. Comp. Neurol. 504, 275-286.
107. Safranek R., Holecek M., Kadlcikova J. et al. (2003) Effect of acute acidosis on protein and amino acid metabolism in rats. Clin. Nutr. 22, 437-443.
108. Safranek R., Ishibashi N., Oka Y., Ozasa H., Shirouzu K., Holecek M. (2006a) Modulation of inflammatory response in sepsis by proteasome inhibition. Int. J. Exp. Pathol. 87, 369-372.
109. Safranek R., Holecek M., Sispera L., Muthny T. (2006b) Aspects of protein and amino acid metabolism in a model of severe glutamine deficiency in sepsis. Ann. Nutr. Metab. 50, 361-367.
110. Sakkas G.K., Ball D., Mercer T.H., Sargeant A.J., Tolfrey K., Naish P.F. (2003) Atrophy of non-locomotor muscle in patients with end-stage renal failure. Nephrol. Dial. Transplant. 18, 2074-2081.
111. Schakman O., Gilson H., de Coninck V. et al. (2005) Insulin-like growth factor-I gene transfer by electroporation prevents skeletal muscle atrophy in glucocorticoid-treated rats. Endocrinology 146, 1789-1797.
112. Schols A.M., Soeters P.B., Dingemans A.M., Mostert R., Frantzen P.J., Wouters E.F. (1993) Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am. Rev. Respir. Dis. 147, 1151-1156.
113. Schotanus K., Holtkamp G.M., van Rooijen N., Tilders F.J., Berkenbosch F. (1995) Circulating tumor necrosis factor-alpha does not mediate endotoxin-induced hypothermia in rats. Am. J. Physiol. 268, R989-R996.
114. Schott K., Poetter U., Neuhoff V. (1984) Ammonia inhibits protein synthesis in slices from young rat brain. J. Neurochem. 42, 644-646.
115. Schulze P.C., Linke A., Schoene N. et al. (2004) Functional and morphological skeletal muscle abnormalities correlate with reduced electromyographic activity in chronic heart failure. Eur. J. Cardiovasc. Prev. Rehabil. 11, 155-161.
116. Shapiro S.D. (2000) Animal models for chronic obstructive pulmonary disease: age of klotho and marlboro mice. Am. J. Respir. Cell Mol. Biol. 22, 4-7.
117. Shaw J.H.F. & Wolfe R.R. (1989) An integrated analysis of glucose, fat, and protein metabolism in severely traumatized patients: studies in the basal state and the response to total parenteral nutrition. Ann. Surg. 209, 63-72.
118. Singleton K.D. & Wischmeyer P.E. (2003) Distance of cecum ligated influences mortality, tumor necrosis factor-alpha and interleukin-6 expression following cecal ligation and puncture in the rat. Eur. Surg. Res. 35, 486-491.
119. Steffen B.T., Lees S.J., Booth F.W. (2008) Anti-TNF treatment reduces rat skeletal muscle wasting in monocrotaline-induced cardiac cachexia. J. Appl. Physiol. 105, 1950-1958.
120. Strassburg S., Springer J., Anker S.D. (2005) Muscle wasting in cardiac cachexia. Int. J. Biochem. Cell Biol. 37, 1938-1947.
121. Streate S.J., Beddoe A.H., Hill G.L. (1987) Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients. J. Trauma 27, 262-266.
122. Strelkov A.B., Fields A.L., Baracos V.E. (1989) Effects of systemic inhibition of prostaglandin production on protein metabolism in tumor-bearing rats. Am. J. Physiol. 257, C261-C269.
123. Supinski G.S., Vanags J., Callahan L.A. (2009) Effect of proteasome inhibitors on endotoxin-induced diaphragm dysfunction. Am. J. Physiol. 296, L994-L1001.
124. Svaninger G., Bennegard K., Ekman L., Ternell M., Lundholm K. (1983) Lack of evidence for elevated breakdown rate of skeletal muscles in weight-losing, tumor-bearing mice. J. Natl Cancer Inst. 71, 341-346.
125. Swallow E.B., Reyes D., Hopkinson N.S. et al. (2007) Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 62, 115-120.
126. Swart G.R., van den Berg J.W.Q, Wattimena J.L.D., Rietveld T., van Vuure J.K., Frenkel M. (1988) Elevated protein requirements in cirrhosis of the liver investigated by whole-body protein turnover studies. Clin. Sci. 75, 101-107.
127. Tan B.H. & Fearon K.C. (2008) Cachexia: prevalence and impact in medicine. Curr. Opin. Clin. Nutr. Metab. Care 11, 400-407.
128. Teplan V., Schück O., Horackova M., Skibova J., Holecek M. (2000) Effect of a keto acid - amino acid supplement on the metabolism and renal elimination of branched-chain amino acids in patients with chronic renal insufficiency on a low protein diet. Wien. Klin. Wochenschr. 112, 876-881.
129. Tessitore L., Bonelli G., Baccino F.M. (1987) Early development of protein metabolic perturbations in the liver and skeletal muscle of tumour-bearing rats. A model system for cancer cachexia. Biochem. J. 241, 153-159.
130. Tessitore L., Costell P., Baccino F.M. (1993) Humoral mediation for cachexia in tumour-bearing rats. Br. J. Cancer 67, 15-23.
131. Tisdale M.J. (2002) Cachexia in cancer patients. Nat. Rev. Cancer 2, 862-871.
132. Utaka S., Avesani C.M., Draibe S.A., Kamimura M.A., Andreoni S., Cuppari L. (2005) Inflammation is associated with increased energy expenditure in patients with chronic kidney disease. Am. J. Clin. Nutr. 82, 801-805.
133. Ventrucci G., Mello M.A., Gomes-Marcondes M.C. (2004) Proteasome activity is altered in skeletal muscle tissue of tumour-bearing rats a leucine-rich diet. Endocr. Relat. Cancer 11, 887-895.
134. Vescovo G., Ravara B., Gobbo V. et al. (2002) L-Carnitine: a potential treatment for blocking apoptosis and preventing skeletal muscle myopathy in heart failure. Am. J. Physiol. 283, C802-C810.
135. Voisin L., Breuillé D., Combaret L. et al. (1996) Muscle wasting in a rat model of long-lasting sepsis results from the activation of lysosomal, Ca2+ -activated, and ubiquitin-proteasome proteolytic pathways. J. Clin. Invest. 97, 1610-1617.
136. Weber F.L., Macechko P.T., Kelson S.R., Karajiannis E., Hassan M.O. (1992) Increased muscle protein catabolism caused by carbon tetrachloride hepatic injury in rats. Gastroenterology 102, 1700-1706.
137. Weiner P., Azgad Y., Weiner M. (1993) The effect of corticosteroids on inspiratory muscle performance in humans. Chest 104, 1788-1791.
138. White J.P., Baynes J.W., Welle S.L. et al. (2011) The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min/+) mouse. PLoS ONE 6, e24650.
139. Wright J.L., Churg A. (1990) Cigarette smoke causes physiologic and morphologic changes of emphysema in the guinea pig. Am. Rev. Respir. Dis. 142, 1422-1428.
140. Yano C.L, Ventrucci G., Field W.N., Tisdale M.J., Gomes-Marcondes M.C. (2008) Metabolic and morphological alterations induced by proteolysis-inducing factor from Walker tumour-bearing rats in C2C12 myotubes. BMC Cancer 8, 24.
141. Zamir O., O'Brien W., Thompson R., Bloedow D.C., Fischer J.E., Hasselgren P.O. (1994) Reduced muscle protein breakdown in septic rats following treatment with interleukin-1 receptor antagonist. Int. J. Biochem. 26, 943-950.
142. Zantl N., Uebe A., Neumann B. et al. (1998) Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis. Infect. Immun. 66, 2300-2309.
143. Zhao W., Pan J., Zhao Z., Wu Y., Bauman W.A., Cardozo C.P. (2008) Testosterone protects against dexamethasone-induced muscle atrophy, protein degradation and MAFbx upregulation. J. Steroid Biochem. Mol. Biol. 110, 125-129.
144. Zhou X., Wang J.L., Lu J. et al. (2010) Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell 142, 531-543.